Immune interactions at the maternal-fetal interface: A focus on antigen presentation

American Journal of Reproductive Immunology

Volumn 51, Issue 4, 2004, Pages 283-289

  Huddleston, Heather ^a   Schust, Danny J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Immune evasion; MHC; Placenta; Virus

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE ANTIGEN; VIRUS ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; CELL STRUCTURE; CELLULAR IMMUNITY; CYTOTROPHOBLAST; DOWN REGULATION; FEMALE; FETUS; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; MOTHER FETUS RELATIONSHIP; NATURAL KILLER CELL; PLACENTA; PRIORITY JOURNAL; REVIEW; TROPHOBLAST;

EID: 1842575539     PISSN: 10467408     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2004.00157.x     Document Type: Review

References (64)

1. Hill J, Polgar K, Anderson D: T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 1995; 273:1933-1936.
2. Piccinni M, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S: Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 1998; 4:1020-1024.
3. Thellin O, Coumans B, Zorzi W, Ignout A, Heinen E: Tolerance to the foeto-placental 'graft': Ten ways to support a child for nine months. Curr Opin Immunol 2000; 12:731-737.
4. Munn D, Zhou M, Attwood J, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL: Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281:1191-1193.
5. Munn D, Shafizadeh E, Attwood J, Bondarev I, Pashine A, Mellor A: Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 1999; 189:1363-1372.
6. Roussev R, Coulam C, Kaider B, Yarkoni M, Leavis P, Barnea E: Embryonic origin of preimplantation factor (PIF): Biological activity and partial characterization. Mol Hum Reprod 1996; 2:883-887.
7. Barnea E, Simon J, Levine S, Coulam C, Taliadouros G, Leavis P: Progress in characterization of pre-implantation factor in embryo cultures and in vivo. Am J Reprod Immunol 1999; 42:95-99.
8. Fahey J and Wira C: Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. J Infect Dis 2002; 185:1606-1613.
9. Siiteri P, Febres F, Clemens L, Chang R, Gondos B, Stites D: Progesterone and maintenance of pregnancy: Is progesterone nature's immunosuppressant? Ann N Y Acad Sci 1977; 286:384-397.
10. Schust D and Hill J: Recurrent pregnancy loss. In Novak's Gynecology, J Berek (ed.). Philadelphia, Lippincott Williams & Wilkins, 2002, pp 1067-1108.
11. Norwitz E, Schust D and Fisher S: Mechanisms of disease: implantation and survival of early pregnancy. N Eng J Med 2001; 345:1400-1408.
12. Ploegh H: Biosynthesis and assembly of MHC antigens. Scand J Rheumatol Suppl 1990; 87:32-35.
13. Ljunggren HG and Karre K: In search of the missing self: MHC molecule and NK cell recognition. Immunol Today 1990; 11:237-244.
14. Sernee MF, Ploegh HL and Schust DJ: Why certain antibodies cross-react with HLA-A and HLA-G: Epitope mapping of two common MHC class I reagents. Mol Immunol 1998; 35:177-188.
15. Zemmour J and Parham P: Distinctive polymorphism at the HLA-C locus: Implications for the expression of HLA-C. J Exp Med 1992; 176:937-950.
16. Le Bouteiller P and Solier C: Is antigen presentation the primary function of HLA-G? Microbes Infect 2001; 3:323-332.
17. Sanders S, Giblin P and Kavathas P: Cell-cell adhesion mediated by CD8 and human histocompatibility leukocyte antigen G, a nonclassical major histocompatibility complex class I molecule on cytotrophoblast. J Exp Med 1991; 174:737-740.
18. Lee N, Malacko A, Ishitani A, Chen MC, Bajorath J, Marquardt H, Geraghty DE: The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 1995; 3:591-600.
19. Moretta L, Biassoni R, Bottino C, Cantoni C, Pende D, Mingari MC, Moretta A: Human NK cells and their receptors. Microbes Infect 2002; 4:1539-1544.
20. Cerwenka A and Lanier L: Ligands for natural killer cell receptors: Redundancy or specificity. Immunol Rev 2001; 181:158-169.
21. Borrego F, Kabat J, Kim D, Lieto L, Maasho K, Pana J, Solana R, Coligan JE: Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol Immunol 2002; 38:637-660.
22. Reyburn H, Mandelboim O, Vales-Gomez M, Sheu EG, Pazmany L, Davis DM, Ttrominger JL: Human NK cells: their ligands, receptors and functions. Immunol Rev 1997; 155:119-125.
23. Pazmany L, Mandelboim O, Vales-Gomez M, Davis D, Reyburn H, Strominger J: Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 1996; 274:792-795.
24. Mandelboim O, Reyburn H, Sheu E, Vales-Gomez M, Davis D, Pazmany L, Strominger JL: The binding site of NK receptors on HLA-C molecules. Immunity 1997; 6:341-350.
25. King A, Allan D, Bowen M, Powis SJ, Joseph S, Verma S, Hiby SE, McMicheal AJ, Loke YW, Braud VM: HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol 2000; 30:1623-1631.
26. Navarro F, Llano M, Bellon T, Colonna M, Geraghty D, Lopez-Botet M: The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol 1999; 29:277-283.
27. Lemberg M, Bland F, Weihofen A, Braud V, Martoglio B: Intramembrane proteolysis of signal peptides: An essential step in the generation of HLA-E epitopes. J Immunol 2001; 167:6441-6446.
28. Stevens J, Joly E, Trowsdale J, Butcher G: Peptide binding characteristics of the non-classical class Ib MHC molecule HLA-E assessed by recombinant random peptide approach. BMC Immunol 2001; 2:5.
29. Lopez-Botet M, Navarro F, Llano M: How do NK cells sense the expression of HLA-G class Ib molecules? Semin Cancer Biol 1999; 9:19-26.
30. Loke YW, King A: Decidual natural-killer-cell interaction with trophoblast: Cytolysis or cytokine production? Biochem Soc Trans 2000; 28:196-198.
31. Moffett-King A: Natural killer cells and pregnancy. Nat Rev Immunol 2002; 2:656-663.
32. Bulmer J, Sunderland C: Immunohistological characterization of lymphoid cell populations in the early human placental bed. Immunology 1984; 52:349-357.
33. Bulmer JN, Johnson PM: Immunohistological characterization of the decidual leucocytic infiltrate related to endometrial gland epithelium in early human pregnancy. Immunology 1985; 55:35-44.
34. Deniz G, Christmas SE, Brew R, Johnson PM: Phenotypic and functional cellular differences between human CD3- decidual and peripheral blood leukocytes. J Immunol 1994; 152:4255-4261.
35. Heyborne K, Cranfill R, Carding S, Born W, O'Brien R: Characterization of gamma delta T lymphocytes at the maternal-fetal interface. J Immunol 1992; 149:2872-2878.
36. Boyson J, Rybalov B, Koopman L, Exley M, Balk SP, Racke FK, Schatz F, Masch R, Wilson SB, Strominger JL: CD1d and invariant NKT cells at the human maternal-fetal interface. Proc Natl Acad Sci USA 2002; 99:13741-13746.
37. Kronenberg M, Gapin L: The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002; 2:557-558.
38. Moretta L, Romagnani S, Pietra G, Moretta A, Mingari M: NK-CTLs, a novel HLA-E-restricted T-cell subset. Trends Immunol 2003; 24:136-143.
39. Rouas-Freiss N, Khalil-Daher I, Riteau B, Menier C, Paul P, Dausset J, Carosella ED: The immunotolerance role of HLA-G. Semin Cancer Biol 1999; 9:3-12.
40. Ishitani A, Geraghty D: Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A 1992; 89:3947-3951.
41. Fujii T, Ishitani A, Geraghty D: A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 1994; 153:5516-5524.
42. Rebmann V, Pfeiffer K, Passler M, Ferrone S, Maier S, Weiss E, Grosse-Wilde H: Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 1999; 53:14-22.
43. McMaster M, Zhou Y, Shorter K, Kapasi D, Geraghty D, Lim KH, Fisher S: HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation. J Immunol 1998; 160:5922-5928.
44. Hunt J, Jadhav L, Chu W, Geraghty D, Ober C: Soluble HLA-G circulates in maternal blood during pregnancy. Am J Obstet Gynecol 2000; 183:682-688.
45. Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, Scarselli B, Bencini E, Menicucco A, Baricordi OR: HLA-G expression in early embryos is a fundamental pre-requisite for the obtainment of pregnancy. Eur J Immunol 2002; 32:311-315.
46. Kuipers J, Bialowons A, Dollmann P, Jendro MC, Wagener N, Rebmann V, Ikeda M, Huang F, Grosse-Wilde H, Yu DT, Zeidler H, Marker-Hermann E: The genetically-engineered secretory B27/Q10 chimeric molecule inhibits HLA-B27 restricted alloreactive T-lymphocytes. Clin Exp Rheumatol 2002; 20:455-462.
47. Contini P, Ghio M, Poggi A, Filaci G, Indiveri F, Ferrone S, Puppo F: Soluble HLA-A, -B, -C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 2003; 33:125-134.
48. Fournel S, Aguerre-Girr M, Huc X, Lenfant F, Alam A, Toubert A, BensuSsan A, Le Bouteiller P: Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000; 164:6100-6104.
49. Solier C, Aguerre-Girr M, Lenfant F, Campan A, Berrebi A, Rebmann V, Grosse-Wilde H, Le Bouteiller P: Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. Eur J immunol 2002; 32:3576-3586.
50. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella E: Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: A CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A 2001; 98:12150-12155.
51. Emmer P, Steegers E, Van Lierop M, et al.: Levels of soluble HLA-G in amniotic fluid are related to the sex of the offspring. Eur J Immunogenet 2003; 30:163-164.
52. Tortorella D, Gewurz B, Furman M, Schust D, Ploegh H: Viral subversion of the immune system. Annu Rev Immunol 2000; 18:861-926.
53. Altshuler G: Immunologic competence of the immature human fetus: Morphologic evidence from intrauterine cytomegalovirus infection. Obstet Gynecol 1974; 43:811-816.
54. Beersma MF, Bijlmakers MJ, Ploegh HL: Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. J Immunol 1993; 151:4455-4464.
55. Machold R, Wiertz E, Jones T, Ploegh H: The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine MHC class I heavy chains. J Exp Med 1997; 185:363-366.
56. Jones TR, Hanson LK, Sun L, Slater JS, Stenberg RM, Campbell AE: Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J Virol 1995; 69:4830-4841.
57. Gewurz B, Gaudet R, Tortorella D, Wang E, Ploegh H, Wiley D: Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2. Proc Natl Acad Sci U S A 2001;98:6794-6799.
58. Wiertz EJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL: The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 1996; 84:769-779.
59. Wiertz EJ, Tortorella D, Bogyo M, Yu J, Mothes W, Jones TR, Rapoport TA, Ploegh H: Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction [see comments]. Nature 1996; 384:432-438.
60. Schust DJ, Tortorella D, Seebach J, Phan C, Ploegh HL: Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J Exp Med 1998; 188:497-503.
61. Schust DJ, Tortorella D, Ploegh HL: HLA-G and HLA-C at the feto-maternal interface: Lessons learned from pathogenic viruses. Semin Cancer Biol 1999; 9:37-46.
62. Furman M, Ploegh H, Schust D: Can viruses help us to understand and classify the MHC class I molecules at the maternal-fetal interface? Hum Immunol 2000; 61:1169-1176.
63. Cohen GB, Gandhi RT, Davis DM, Mandelboim O, Chen BK, Strominger JL, Baltimore D: The selective down-regulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999; 10:661-671.
64. Ishido S, Wang C, Lee BS, Cohen GB, Jung JU: Down-regulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpes virus K3 and K5 proteins. J Virol 2000; 74:5300-5309.